Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions. Approval in the U.S.–Novo’s biggest market for obesity drugs–by the ...

Novo nearly doubled its TV ad spending for Wegovy in March, laying out $40.4 million for the month, compared to $25.8 million in February, when it took third place. J&J, meanwhile, spent $32.6 ...

Novo Nordisk’s move to cut ties with Hims & Hers serves as a warning about the dangers of using unapproved, compounded weight loss drugs that may come from unverified international suppliers.

COPENHAGEN (Reuters) -Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending shares of the U.S. telehealth company plunging ...

Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities worldwide — all while adding great heft to Denmark's economy.

Novo Nordisk shares rose Wednesday after fourth-quarter earnings beat Wall Street's estimates, 2025 forecast came in line with expectations. Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply ...